| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |